SCHEMBL761009

SCHEMBL761009

CNc1cccn1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7350295 0.77
SCHEMBL27933672 0.73 TDP1 (0.39)
SCHEMBL28194790 0.72
SCHEMBL6345896 0.69
SCHEMBL27640631 0.69
Dimethylamine SCHEMBL385867 0.68 TSHR (0.39)
SCHEMBL25755075 0.67 ATM (0.44)
SCHEMBL9232313 0.67 TYK2 (0.40)
SCHEMBL8012516 0.66 RAB9A (0.40)
SCHEMBL197196 0.65 PCSK9 (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633348-B1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES ELAN PHARM INC (US) 2008-10-08 EP claimed
US-20230365544-A1 SMALL MOLECULE INHIBITORS OF CALCIUM CHANNEL ACTIVITY AND USES THEREOF NATIONAL INSTITUTES OF HEALTH 2023-11-16 US disclosed
US-20230340018-A1 MPRO CYSTEINE PROTEASE INHIBITORS ANIXA BIOSCIENCES, INC. 2023-10-26 US disclosed
EP-3582783-B1 7-MEMBERED AZA-HETEROCYCLIC CONTAINING DELTA-OPIOID RECEPTOR MODULATING COMPOUNDS, METHODS OF USING AND MAKING THE SAME TREVENA INC (US) 2023-06-07 EP disclosed
CN-110300578-B Compounds for the treatment of respiratory diseases in cattle or pigs 英特维特国际股份有限公司 2022-12-13 CN disclosed
EP-4086249-A2 6-MEMBERED AZA-HETEROCYCLIC CONTAINING DELTA-OPIOID RECEPTOR MODULATING COMPOUNDS, METHODS OF USING AND MAKING THE SAME Trevena, Inc. (US) 2022-11-09 EP disclosed
CN-107466232-B Methods of treating or preventing RAS-mediated diseases ADT制药有限责任公司 2021-06-29 CN disclosed
CN-112047909-A Indenyl compound, pharmaceutical composition and medical application thereof ADT制药有限责任公司 2020-12-08 CN disclosed
CN-107531615-B Indenyl compound, pharmaceutical composition and medical application thereof ADT制药有限责任公司 2020-09-04 CN disclosed
EP-2970145-B1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CANCER BROAD INST INC (US) 2020-05-06 EP disclosed
EP-2284155-A2 Substituted tetracycline compounds Paratek Pharmaceuticals, Inc. (US) 2011-02-16 EP disclosed
EP-2269978-A2 Substituted tetracycline compounds Paratek Pharmaceuticals, Inc. (US) 2011-01-05 EP disclosed
EP-2269985-A2 Substituted tetracycline compounds Paratek Pharmaceuticals, Inc. (US) 2011-01-05 EP disclosed
EP-2269991-A2 Substituted tetracycline compounds Paratek Pharmaceuticals, Inc. (US) 2011-01-05 EP disclosed
EP-2033950-A1 Substituted tetracycline compounds Paratek Pharmaceuticals, Inc. (US) 2009-03-11 EP disclosed
US-20070282101-A1 Indazole compounds ABBVIE INC. 2007-12-06 US disclosed
EP-1807387-A2 SUBSTITUTED TETRACYCLINE COMPOUNDS Paratek Pharmaceuticals, Inc. (US) 2007-07-18 EP disclosed
US-20060166945-A1 Substituted tetracycline compounds PARATEK PHARMACEUTICALS, INC. (US) 2006-07-27 US disclosed
WO-2006047756-A2 SUBSTITUTED TETRACYCLINE COMPOUNDS PARATEK PHARMACEUTICALS, INC. (US) 2006-05-04 WO disclosed
CN-1084169-A New phenylpyrrole derivative and its production and use SMITHKLINE BEECHAM PLC (GB) 1994-03-23 CN disclosed